Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor

Xingkai Liu, Qian Chen, Xuming Ji, Wanchen Yu, Tong Wang, Juanjuan Han, Shumu Li, Jianan Liu, Fan‐Gang Zeng, Yao Zhao, Yanyan Zhang, Qun Luo, Shijun Wang, Fuyi WangFrontiers in Pharmacology 2022 · DOI

TL;DR

This study investigates how traditional Chinese medicines, Descurainia sophia seeds (DS) and Astragalus mongholicus (AM), treat heart failure. Using advanced proteomics, they found that DS alone is effective, but a specific component of AM, astragaloside IV (AS4), significantly boosts DS's effect by targeting the heart's "myosin motor." This research offers a molecular basis for combining these herbs and highlights the power of proteomics in understanding traditional medicine.

What Problem Does This Paper Address?

Heart failure, particularly dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), is a major health concern. These conditions are often linked to genetic mutations affecting sarcomeric proteins, especially myosin, which controls heart muscle contraction. Traditional Chinese Medicine (TCM) has long used herbs like Descurainia sophia seeds (DS) and Astragalus mongholicus (AM) for heart conditions, but the precise molecular mechanisms behind their effectiveness remain unclear. This paper aims to bridge this knowledge gap by dissecting the molecular impact of DS and AM, and their key components, on isoproterenol-induced cardiomyopathy (ISO-iCM) in rats.

Methods

The researchers employed a multi-faceted approach:

  • Chemical Characterization: Ultra-Performance Liquid Chromatography coupled with Mass Spectrometry (UPLC-MS/MS) was used to identify and quantify the chemical components present in DS and AM decoctions.
  • Animal Model: Isoproterenol (ISO) was used to induce cardiomyopathy in rats, mimicking aspects of heart failure.
  • Proteomics: Mass spectrometry-based quantitative proteomics was the core technique. This allowed for the profiling and comparison of protein expression levels in the heart tissues of control rats, ISO-induced cardiomyopathy rats, and rats treated with various combinations of DS, AM, and specific AM components (astragaloside IV (AS4), calycosin-7-glucoside (C7G), and Astragalus polysaccharides (APS)). This technique is crucial for understanding the molecular changes occurring in the heart.
  • Histopathology: Hematoxylin-eosin (H&E) and Masson's trichrome staining were used to examine the structural changes in heart tissues, assessing features like hypertrophy and fibrosis.
  • Echocardiography: This non-invasive imaging technique was used to evaluate cardiac function, specifically left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS).
  • Western Blotting: This technique was used to validate the expression levels of specific proteins identified by proteomics.
  • Bioinformatics: Tools like STRING and Ingenuity Pathway Analysis (IPA) were used to analyze protein-protein interactions and identify enriched biological pathways and functions associated with the differentially expressed proteins.
  • Principal Component Analysis (PCA): This statistical method was used to visualize the overall effect of different treatments on the proteomic profiles.

Datasets

  • Protein Databases: UniProt database (Rattus norvegicus, version 10/25/2017) was used for protein identification.
  • Metabolite Databases: KEGG, Human Metabolome Database, BroadPharm, Food and Agriculture Organization, xPharm, AQ BioPharma, AxisPharm, BLDpharm, abcr, and PubMed were used for metabolite identification.
  • Proteomics Data: The raw proteomics data is available in the Proteomics Identification Database (ebi.ac.uk/pride/) under accession number 1-20220509-37752.

Key Insights and Ideas

  • DS as a Foundation: Descurainia sophia seeds (DS) alone demonstrate a significant ability to reverse many of the protein expression changes associated with isoproterenol-induced cardiomyopathy (ISO-iCM). This suggests DS is a potent therapeutic agent in its own right.
  • AS4 as a Potent Synergist: The real "aha moment" is the discovery that astragaloside IV (AS4), a key component of Astragalus mongholicus (AM), doesn't just add to DS's effect; it remarkably enhances it. AS4 appears to work by "complementarily reversing" the myosin motor proteins (MYH6/7) and further downregulating key biomarkers like NPPA and MYL4.
  • The "Myosin Motor" as a Target: The study strongly implicates the myosin motor – the molecular machinery responsible for heart muscle contraction – as a critical target for these TCMs. Dysregulation of this motor is a central theme in the development of ISO-iCM.
  • Not All AM Components are Equal: While AS4 is beneficial, Astragalus polysaccharides (APS), another component of AM, actually reduces the effectiveness of DS. This highlights the complexity of herbal combinations and suggests that not all constituents contribute positively.
  • Biomarkers Identified: NPPA (natriuretic peptides A) and MYL4 (sarcomeric myosin light chain 4) are confirmed as significant biomarkers for ISO-iCM, and their modulation by DS and AS4 is a key finding.

Key Results

  • DS Reverses DEPs: DS decoction alone reversed most differentially expressed proteins (DEPs) in ISO-iCM rat hearts, including NPPA and MYL4.
  • AS4 Enhances DS: AS4 significantly boosted DS's pharmacological potency by reversing MYH6/7 expression and further downregulating NPPA and MYL4.
  • APS Impairs DS: APS reduced DS's efficiency by upregulating NPPA and MYL4.
  • Histopathology and Cardiac Function: DS and its combination with AS4 showed improved histopathological features and cardiac function (LVEF, LVFS) compared to the model group.
  • Proteomics Identified Key Players: Proteomics identified 25 differentially expressed proteins, with NPPA, MYH6, MYH7, and MYL4 being particularly significant in the ISO-iCM model.

Limitations and Future Work

  • DS Alone vs. Combinations: While DS alone showed efficacy, the study emphasizes that the combination with AS4 provided the most significant improvement. The paper notes that AM alone had poor pharmacological effects.
  • Unidentified Components in DS: The study identified that DS upregulated MYH7 and downregulated BDH1, but the specific components within DS responsible for these changes were not identified. The authors suggest future work to investigate purified active components of DS, such as quercetin and kaempferol, using proteomics.
  • Complexity of TCM Combinations: The findings underscore that while TCM combinations are crucial, simple mixing of herbs might not always yield optimal results, as seen with the detrimental effect of APS. Further research is needed to understand the synergistic and antagonistic interactions between different components.
  • Translational Potential: While this study provides valuable insights into the molecular mechanisms, further research is needed to translate these findings from rat models to human clinical applications.

Summary updated

Abstract

<i>Descurainia sophia</i> seeds (DS), <i>Astragalus mongholicus</i> (AM), and their formulas are widely used to treat heart failure caused by various cardiac diseases in traditional Chinese medicine practice. However, the molecular mechanism of action of DS and AM has not been completely understood. Herein, we first used mass spectrometry coupled to UPLC to characterize the chemical components of DS and AM decoctions, then applied MS-based quantitative proteomic analysis to profile protein expression in the heart of rats with isoproterenol-induced cardiomyopathy (ISO-iCM) before and after treated with DS alone or combined with AM, astragaloside IV (AS4), calycosin-7-glucoside (C7G), and Astragalus polysaccharides (APS) from AM. We demonstrated for the first time that DS decoction alone could reverse the most of differentially expressed proteins in the heart of the rats with ISO-iCM, including the commonly recognized biomarkers natriuretic peptides (NPPA) of cardiomyopathy and sarcomeric myosin light chain 4 (MYL4), relieving ISO-iCM in rats, but AM did not pronouncedly improve the pharmacological efficiency of DS. Significantly, we revealed that AS4 remarkably promoted the pharmacological potency of DS by complementarily reversing myosin motor MYH6/7, and further downregulating NPPA and MYL4. In contrast, APS reduced the efficiency of DS due to upregulating NPPA and MYL4. These findings not only provide novel insights to better understanding in the combination principle of traditional Chinese medicine but also highlight the power of mass spectrometric proteomics strategy combined with conventional pathological approaches for the traditional medicine research.
BibTeX
@inproceedings{liu2022astragaloside,
  author = {Xingkai Liu and Qian Chen and Xuming Ji and Wanchen Yu and Tong Wang and Juanjuan Han and Shumu Li and Jianan Liu and Fan‐Gang Zeng and Yao Zhao and Yanyan Zhang and Qun Luo and Shijun Wang and Fuyi Wang},
  title = {{Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor}},
  booktitle = {Frontiers in Pharmacology},
  year = {2022},
  doi = {10.3389/fphar.2022.939483},
}
Figure